Generics Cos. Fight Lovenox Injunction In Fed. Circ.

By Christopher Norton · January 24, 2012, 3:25 PM EST

Attorneys for three generic-drug makers on Tuesday urged the Federal Circuit to scrap an injunction barring them from selling a competing generic version of Momenta Pharmaceuticals Inc.'s blood-thinning drug generic of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Christopher

March 06, 2012
Medtronic Had Burden In Device IP Suit, Fed Circ. Told
March 01, 2012
FDA Warns Of 2 Hazardous Chemicals Used In Drugs
March 01, 2012
Reglan Failure-To-Warn Suit Brought To Supreme Court
February 23, 2012
Ex-Unilab Atty Can Pursue FCA Claims, 2nd Circ. Hears
February 22, 2012
Insurer Aims To Duck Coverage Of Omeros FCA Suit
February 10, 2012
Judge Misread Patent Claims, Sanofi Tells Fed. Circ.
February 07, 2012
MGH Didn't Credit Researchers For Patents, Fed. Circ. Hears
February 06, 2012
Wake Forest Blasts Jury Interrogatories In Fed. Circ. IP Case
February 06, 2012
ProMedica Begs FTC Not To Make It Divest Ohio Hospital
February 03, 2012
NLRB Wrongly Awarded Nurses Back Pay, DC Circ. Hears